Literature DB >> 10096227

[The prostitution situation in a number of cities of Russia, Ukraine and Byelarus].

V Lakhumalani1.   

Abstract

The analytical study indicating that 25% of prostitutes use drugs by intravenous injection is presented. As determined in this study, prostitutes face the double danger of being infected with HIV (they undergo treatment for drug addiction and sexually transmitted diseases). The conclusion has been made that no educational work on HIV/AIDS is carried out among this group of women, though they run a high risk of infection. According to this study, the requirements which ensure the health of prostitutes may be realized by itinerary educational programs, the publication of information materials, specially intended for distribution among such women. The necessity to supplement information on AIDS with information on STD is noted, alerting the public on the fact that these infections are closely connected. The necessity of educating transport and industrial workers, as well as people working in the system of the Ministry of Defense, with a view to prevent the spread of HIV infection is also considered to be an important factor (on the example of Belarus).

Entities:  

Mesh:

Year:  1999        PMID: 10096227

Source DB:  PubMed          Journal:  Zh Mikrobiol Epidemiol Immunobiol        ISSN: 0372-9311


  2 in total

1.  Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities.

Authors:  Lucy Platt; Tim Rhodes; Ali Judd; Evgeniya Koshkina; Svetlana Maksimova; Natalia Latishevskaya; Adrian Renton; Tamara McDonald; John V Parry
Journal:  Am J Public Health       Date:  2006-10-03       Impact factor: 9.308

2.  Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia.

Authors:  Lucy Platt; Martin Wall; Tim Rhodes; Ali Judd; Matthew Hickman; Lisa G Johnston; Adrian Renton; Natalia Bobrova; Anya Sarang
Journal:  J Urban Health       Date:  2006-11       Impact factor: 3.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.